MKI67 and breast cancer: Even though the integration of Ki-67 with other diagnostic tools provides a more comprehensive biological analysis of malignant breast tumors, the implementation of additional tests increases the cost of the diagnostic process, affecting accessibility, particularly in developing countries where economic resources are limited.